122 related articles for article (PubMed ID: 11464278)
1. The periodic down regulation of Cyclin E gene expression from exit of mitosis to end of G(1) is controlled by a deacetylase- and E2F-associated bipartite repressor element.
Polanowska J; Fabbrizio E; Le Cam L; Trouche D; Emiliani S; Herrera R; Sardet C
Oncogene; 2001 Jul; 20(31):4115-27. PubMed ID: 11464278
[TBL] [Abstract][Full Text] [Related]
2. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex.
Le Cam L; Polanowska J; Fabbrizio E; Olivier M; Philips A; Ng Eaton E; Classon M; Geng Y; Sardet C
EMBO J; 1999 Apr; 18(7):1878-90. PubMed ID: 10202151
[TBL] [Abstract][Full Text] [Related]
3. Retinoblastoma protein recruits histone deacetylase to repress transcription.
Brehm A; Miska EA; McCance DJ; Reid JL; Bannister AJ; Kouzarides T
Nature; 1998 Feb; 391(6667):597-601. PubMed ID: 9468139
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
Spitkovsky D; Schulze A; Boye B; Jansen-Dürr P
Cell Growth Differ; 1997 Jun; 8(6):699-710. PubMed ID: 9186003
[TBL] [Abstract][Full Text] [Related]
5. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter.
Stiegler P; De Luca A; Bagella L; Giordano A
Cancer Res; 1998 Nov; 58(22):5049-52. PubMed ID: 9823308
[TBL] [Abstract][Full Text] [Related]
6. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes.
Bandyopadhyay D; Okan NA; Bales E; Nascimento L; Cole PA; Medrano EE
Cancer Res; 2002 Nov; 62(21):6231-9. PubMed ID: 12414652
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein.
Geng Y; Eaton EN; Picón M; Roberts JM; Lundberg AS; Gifford A; Sardet C; Weinberg RA
Oncogene; 1996 Mar; 12(6):1173-80. PubMed ID: 8649818
[TBL] [Abstract][Full Text] [Related]
9. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
Araki K; Nakajima Y; Eto K; Ikeda MA
Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
[TBL] [Abstract][Full Text] [Related]
10. Regulation of E2F-1 gene expression in avian cells.
Espanel X; Le Cam L; North S; Sardet C; Brun G; Gillet G
Oncogene; 1998 Aug; 17(5):585-94. PubMed ID: 9704924
[TBL] [Abstract][Full Text] [Related]
11. MyoD activity upregulates E2F1 and enhances transcription from the cyclin E promoter in differentiating myoblasts lacking a functional retinoblastoma protein.
Tedesco D; Vesco C
Exp Cell Res; 2001 Oct; 269(2):301-11. PubMed ID: 11570822
[TBL] [Abstract][Full Text] [Related]
12. The Rb/chromatin connection and epigenetic control: opinion.
Ferreira R; Naguibneva I; Pritchard LL; Ait-Si-Ali S; Harel-Bellan A
Oncogene; 2001 May; 20(24):3128-33. PubMed ID: 11420729
[TBL] [Abstract][Full Text] [Related]
13. Identification of a set of protein species approximately 40 kDa as high-affinity DNA binding factor(s) to the cell cycle regulatory region of the human thymidine kinase promoter.
Kim EC; Rawlings SL; Li LJ; Roy B; Lee AS
Cell Growth Differ; 1996 Dec; 7(12):1741-9. PubMed ID: 8959343
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional control by cell-cycle regulators: a review.
Lania L; Majello B; Napolitano G
J Cell Physiol; 1999 May; 179(2):134-41. PubMed ID: 10199552
[TBL] [Abstract][Full Text] [Related]
15. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
[TBL] [Abstract][Full Text] [Related]
16. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation.
Yamada M; Kondo T; Ashizawa S; Takebayashi T; Higashi H; Hatakeyama M
Cytokine; 2002 Jan; 17(2):91-7. PubMed ID: 11886176
[TBL] [Abstract][Full Text] [Related]
17. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K
Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of E2F-dependent activation and pRB-mediated repression.
Frolov MV; Dyson NJ
J Cell Sci; 2004 May; 117(Pt 11):2173-81. PubMed ID: 15126619
[TBL] [Abstract][Full Text] [Related]
19. E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases.
Tyagi S; Chabes AL; Wysocka J; Herr W
Mol Cell; 2007 Jul; 27(1):107-19. PubMed ID: 17612494
[TBL] [Abstract][Full Text] [Related]
20. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells.
Radkov SA; Kellam P; Boshoff C
Nat Med; 2000 Oct; 6(10):1121-7. PubMed ID: 11017143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
